The subcutaneous defibrillator will replace the transvenous defibrillator

The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The New England Journal of Medicine, 337(22), 1576–1583A.CrossRefGoogle Scholar

Moss, A., Zareba, W., Hall, J., Klein, H., Wilber, D., Cannom, D., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346(12), 877–883.PubMedCrossRefGoogle Scholar

Bardy, G., Lee, K., Mark, D., Poole, J., Packer, D., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352(3), 225–237.PubMedCrossRefGoogle Scholar

Maisal, W., & Kramer, D. (2008). Implantable cardioverter-defibrillator lead performance. Circulation, 117(21), 2721–2723.CrossRefGoogle Scholar

Alter, P., Waldhans, S., Plachta, E., Moosdorf, R., & Grimm, W. (2005). Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing and Clinical Electrophysiology, 28(9), 926–932.PubMedCrossRefGoogle Scholar

Bardy, G., Smith, W., Hood, M., Crozier, I., Melton, I., Jordaens, L., et al. (2010). An entirely subcutaneous implantable cardioverter-defibrillator. The New England Journal of Medicine, 363(1), 36–44.PubMedCrossRefGoogle Scholar

Gold, M., Theuns, D., Knight, B., Sturdivant, J., Ellenbogen, K., Wood, M., et al. (2009). Arrhythmia detection by a totally subcutaneous S-ICD® system compared to transvenous single-chamber ICD systems with morphology discrimination. Heart Rhythm, 6(5S), S34.Google Scholar

Wathen, M., DeGroot, P., Sweeney, M., Stark, A., Otterness, M., Adkisson, W., et al. (2004). Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation, 110(17), 2591–2596.PubMedCrossRefGoogle Scholar

Lerman, B., & Deale, O. (1990). Relation between transcardiac and transthoracic current during defibrillation in humans. Circulation Research, 67(6), 1420–1426.PubMedGoogle Scholar

Jolley, M., Stinstra, J., Pieper, S., MacLeod, R., Brooks, D., Cecchin, F., et al. (2008). A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm, 5(4), 565–572.PubMedCrossRefGoogle Scholar

Tung, L., Tovar, O., Neunlist, M., Jain, S., & O’Neill, R. (1994). Effects of strong electrical shock on cardiac muscle tissue. Annals of the New York Academy of Sciences, 720, 160–175.PubMedCrossRefGoogle Scholar

Walcott, G., Killingsworth, C., & Ideker, R. (2003). Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction? Resuscitation, 59, 59–70.PubMedCrossRefGoogle Scholar

Hasdemir, C., Shan, N., Rao, A., Acosta, H., Matsudaira, K., Neas, B., et al. (2002). Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. Journal of Cardiovascular Electrophysiology, 13(2), 144–150.PubMedCrossRefGoogle Scholar

Tokano, T., Bach, D., Chang, J., Davis, J., Souza, J., Zivin, A., et al. (1998). Effect of ventricular shock strength on cardiac hemodynamics. Journal of Cardiovascular Electrophysiology, 9(8), 791–797.PubMedCrossRefGoogle Scholar

Zivin, A., Souza, J., Pelosi, F., Flemming, M., Knight, B., Goyal, R., et al. (1999). Relationship between shock energy and postdefibrillation ventricular arrhythmias in patients with implantable defibrillators. Journal of Cardiovascular Electrophysiology, 10(3), 370–377.PubMedCrossRefGoogle Scholar

Killingworth, C., Livotsky, S., Melnick, S., Vance, F., Ideker, R., & Walcott, G. (2010). Shocks delivered via a subcutaneous defibrillation system cause less acute injury than transvenous leads in swine. Heart Rhythm, 7(5S), S186.Google Scholar

Poole, J., Johnson, G., Hellkamp, A., Anderson, J., Callans, D., Raitt, M., et al. (2008). Prognostic importance of defibrillator shocks in patients with heart failure. The New England Journal of Medicine, 359(10), 1009–1017.PubMedCrossRefGoogle Scholar

Hohnloser, S., Kuck, K., Dorian, P., Roberts, R., Hampton, J., Hatala, R., et al. (2004). Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. The New England Journal of Medicine, 351(24), 2481–2488.PubMedCrossRefGoogle Scholar

The DAVID trial Investigators. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. Journal of the American Medical Association, 288(24), 3115–3123.CrossRefGoogle Scholar

Sweeney, M., Ruetz, L., Belk, P., Mullen, T., Johnson, J., & Sheldon, T. (2007). Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachycardias a possible mechanism of proarrhythmia? Journal of the American College of Cardiology, 50(7), 614–622.PubMedCrossRefGoogle Scholar

Himmrich, E., Przibille, O., Zellerhoff, C., Liebrich, A., Rosocha, S., Andreas, K., et al. (2003). Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators. Circulation, 108(2), 192–197.PubMedCrossRefGoogle Scholar